Humanin improves impaired metabolic activity and prolongs survival of serum-deprived human lymphocytes

Molecular and Cellular Biochemistry

Volumn 254, Issue 1-2, 2003, Pages 83-89

  Kariya, Shingo ^a   Takahashi, Nobuyuki ^a   Hirano, Makito ^a   Ueno, Satoshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Human lymphocyte; Humanin; Metabolic activity; Serum deprivation

Indexed keywords

BRAIN PEPTIDE; HUMANIN; UNCLASSIFIED DRUG;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN ISCHEMIA; CELL ACTIVITY; CELL ASSAY; CELL DEATH; CELL METABOLISM; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; DRUG INDICATION; DRUG POTENCY; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOCYTE CULTURE; METABOLIC DISORDER; MITOCHONDRION; NEUROPROTECTION; SERUM; SURVIVAL RATE;

ADULT; ALZHEIMER DISEASE; APOPTOSIS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; DNA; DNA FRAGMENTATION; DNA, MITOCHONDRIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENISTEIN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; PEPTIDES; POLYMERASE CHAIN REACTION; PROTEINS; TIME FACTORS;

EID: 0344034355     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027372519726     Document Type: Article

References (25)

1. Selkoe DJ: Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease. Review. Trends Neurosci 16: 403-409, 1993
2. Ashall F, Goate AM: Role of the beta-amyloid precursor protein in Alzheimer's disease. Review. Trends Biochem Sci 19: 42-46, 1994
3. Checler F: Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease. Review. J Neurochem 65: 1431-1444, 1995
4. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 21: 704-706, 1991
5. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760, 1995
6. Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KA, Weber JL, Bird TD, Schellenberg GD: A familial Alzheimer's disease locus on chromosome 1. Science 269: 970-973, 1995
7. Cummings JL, Vinters HV, Cole GM, Khachaturian ZS: Alzheimer's disease: Etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Review. Neurology 51: S2-S17; discussion S65-S67, 1998
8. Fassbender K, Masters C, Beyreuther K: Alzheimer's disease: Molecular concepts and therapeutic targets. Review. Naturwissenschaften 88: 261-267, 2001
9. Hashimoto Y, Niikura T, Tajima H, Yasukawa T, Sudo H, Ito Y, Kita Y, Kawasumi M, Kouyama K, Doyu M, Sobue G, Koide T, Tsuji S, Lang J, Kurokawa K, Nishimoto I: A novel rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ. Proc Natl Acad Sci USA 98: 6336-6341, 2001
10. Hashimoto Y, Niikura T, Ito Y, Sudo H, Hata M, Arakawa E, Abe Y, Kita Y, Nishimoto I: Detailed characterization of neuroprotection by a rescue factor Humanin against various Alzheimer's disease-relevant insults. J Neurosci 21: 9235-9245, 2001
11. Hashimoto Y, Ito Y, Niikura T, Shao Z, Hata M, Oyama F, Nishimoto I: Mechanisms of neuroprotection by a novel rescue factor Humanin from Swedish mutant amyloid precursor protein. Biochem Biophys Res Commun 283: 460-468, 2001
12. Kariya S, Takahashi N, Ooba N, Kawahara M, Nakayama H, Ueno S: Humanin inhibits cell death of serum-deprived PC12h cells. Neuroreport 13: 903-907, 2002
13. Alnemri ES: Hidden powers of the mitochondria. Nature Cell Biol 43: 465-475, 1999
14. Berridge MV, Tan AS: Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): Subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 303: 474-482, 1993
15. McElroy WD, DeLuca MA: Firefly and bacterial luminescence: basic science and applications. J Appl Biochem 5: 197-209, 1983
16. Ebstein RP, Nemanov L, Lubarski G, Dano M, Trevis T, Korczyn AD: Changes in expression of lymphocyte amyloid precursor protein mRNA isoforms in normal aging and Alzheimer's disease. Mol Brain Res 35: 260-268, 1996
17. Batistatou A, Greene LA: Internucleosomal DNA cleavage and neuronal cell survival/death. J Cell Biol 122: 523-532, 1993
18. 1. Biochem Biophys Res Commun 277: 487-493, 2000
19. Atabay C, Cagnoli CM, Kharlamov E, Ikomovic MD, Manev H: Removal of serum from primary cultures of cerebellar granule neurons induces oxidative stress and DNA fragmentation: Protection with antioxidants and glutamate receptor antagonists. J Neurosci Res 43: 465-475, 1996
20. Barrientos A, Casademont J, Cardellach F, Estivill X, Urbano-Marquez A, Nunes V: Reduced steady-state levels of mitochondrial RNA and increased mitochondrial DNA amount in human brain with aging. Mol Brain Res 52: 284-289, 1997
21. Tokunaga M, Mita S, Sakuta R, Nonaka I, Araki S: Increased mitochondrial DNA in blood vessels and ragged-red fibers in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Ann Neurol 33: 275-280, 1993
22. Papa S, Skulachev VP: Reactive oxygen species, mitochondria, apoptosis and aging. Mol Cell Biochem 174: 305-319, 1997
23. Rusanen H, Majamaa K, Hassinen IE: Increased activities of antioxidant enzymes and decreased ATP concentration in cultured myoblasts with the 3243A → G mutation in mitochondrial DNA. Biochim Biophys Acta 1500: 10-16, 2000
24. Harris LK, Black RT, Golden KM, Reeves TM, Povlishock JT, Phillips LL: Traumatic brain injury-induced changes in gene expression and functional activity of mitochondrial cytochrome C oxidase. J Neurotrauma 18: 993-1009, 2001
25. Abel MS, McCandless DW: Elevated gamma-aminobutyric acid levels attenuate the metabolic response to bilateral ischemia. J Neurochem 58: 740-744, 1992